Bayer to acquire TPG-backed Asklepios Bio worth up to $4 billion

Bayer to acquire TPG-backed Asklepios Bio worth up to $4 billion

Bayer agreed to acquire unlisted U.S. biotech firm Asklepios BioPharmaceutical Inc for as much as $4 billion in a bet on gene therapy with the help of modified viruses. Germany’s Bayer will pay $2 billion upfront and up to an additional $2 billion in milestone...
Jon Moulton warns of Brexit impact on private equity

Jon Moulton warns of Brexit impact on private equity

Jon Moulton, the veteran private equity boss, was a vocal supporter of leaving the European Union in the run-up to the UK’s in-out referendum on EU membership. Now, though, he fears Brexit could have a devastating impact on the UK’s financial services sector when the...
Dunkin’ Brands Near Deal for $9 Billion Sale to Inspire Brands

Dunkin’ Brands Near Deal for $9 Billion Sale to Inspire Brands

Dunkin’ Brands Group, Inc., the parent company of donuts chain Dunkin’ and Baskin-Robbins, said it’s in talks to be acquired by private equity-backed Inspire Brands. The New York Times earlier reported the talks, saying that Inspire will take Dunkin’ private at...
TalkTalk in arrears with BT as it prepares call on buy-out

TalkTalk in arrears with BT as it prepares call on buy-out

TalkTalk is locked in dispute with the network arm of BT over an unpaid broadband bill of more than £10m, as it attempts to disconnect from the stock market with a private equity buy-out. Four industry sources said TalkTalk had not paid a chunk of the fees it owes...